Bioventix (BVXP)

Sector:

Pharma and Biotech

Index:

FTSE AIM 100

4,423.08p
   
  • Change Today:
    -26.92p
  • 52 Week High: 5,060.00
  • 52 Week Low: 3,500.00
  • Currency: UK Pounds
  • Shares Issued: 5.22m
  • Volume: 583
  • Market Cap: £230.87m
Select chart: 1 week
 

Current

3 month

Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
30-Jun-24 14.00 11.20 166.20p 26.8 7.7 +4% 161.00p 0.0%
30-Jun-25 15.10 12.10 179.30p 24.8 3.1 +8% 172.00p 0.0%

Copyright © 2024 FactSet Research Systems Inc. All rights reserved.

Trends & Recommendations

  Current 1 week ago 1 month ago 3 months ago 6 months ago 1 year ago
Revenue (£m)
30-Jun-2024 14 14 n/a n/a n/a n/a
30-Jun-2025 15 15 n/a n/a n/a n/a
 
Earnings
30-Jun-2024 166.20p 166.20p n/a n/a n/a n/a
30-Jun-2025 179.30p 179.30p n/a n/a n/a n/a
 
Dividend
30-Jun-2024 161.00p 161.00p n/a n/a n/a n/a
30-Jun-2025 172.00p 172.00p n/a n/a n/a n/a
 
Recommendations
Strong Buy 0 0 0 0 0 0
Buy 0 0 0 0 0 0
Neutral 0 0 0 0 0 0
Sell 0 0 0 0 0 0
Strong Sell 0 0 0 0 0 0
No. of Brokers 0 0 0 0 0 0
 
Average Rec n/a n/a n/a n/a n/a n/a

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Broker estimates sourced from FactSet Estimates +44 (0) 20 3009 7000. FactSet Estimates calculate consensus using only those estimates changed or actively validated within the last 75 days.

Note 3: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 4: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

Bioventix Market Data

Currency UK Pounds
Share Price 4,423.08p
Change Today -26.92p
% Change -0.61 %
52 Week High 5,060.00
52 Week Low 3,500.00
Volume 583
Shares Issued 5.22m
Market Cap £230.87m

Bioventix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
98.28% below the market average98.28% below the market average98.28% below the market average98.28% below the market average98.28% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Price Trend
74.51% above the market average74.51% above the market average74.51% above the market average74.51% above the market average74.51% above the market average
92.86% above the sector average92.86% above the sector average92.86% above the sector average92.86% above the sector average92.86% above the sector average
Income
29.66% below the market average29.66% below the market average29.66% below the market average29.66% below the market average29.66% below the market average
Sector averageSector averageSector averageSector averageSector average
Growth
34.04% below the market average34.04% below the market average34.04% below the market average34.04% below the market average34.04% below the market average
27.78% above the sector average27.78% above the sector average27.78% above the sector average27.78% above the sector average27.78% above the sector average

Bioventix Dividends

  Latest Previous
  1st Interim 2nd Interim
Ex-Div 11-Apr-24 09-Nov-23
Paid 26-Apr-24 24-Nov-23
Amount 68.00p 90.00p

Trades for 29-Apr-2024

Time Volume / Share Price
11:44 18 @ 4,463.00p
10:59 60 @ 4,463.50p
10:59 102 @ 4,420.00p
10:58 2 @ 4,490.00p
10:51 40 @ 4,463.00p

Bioventix Key Personnel

CEO Peter John Harrison
Chair Ian James Nicholson
CFO Bruce Hiscock

Top of Page